A
CORT icon

AlphaQuest’s Corcept Therapeutics CORT Stock Holding History

AlphaQuest’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-88
Closed -$3.06K – 460
2025
Q4 		$3.06K Buy
88
+8
+10% +$628 ﹤0.01% 2198
2025
Q3 		$6.65K Sell
80
-679
-89% -$49.1K ﹤0.01% 2180
2025
Q2 		$55.7K Sell
759
-2,588
-77% -$188K 0.01% 1598
2025
Q1 		$382K Sell
3,347
-4,146
-55% -$252K 0.04% 651
2024
Q4 		$378K Sell
7,493
-1,763
-19% -$92.4K 0.05% 603
2024
Q3 		$428K Buy
9,256
+3,990
+76% +$142K 0.04% 724
2024
Q2 		$171K Buy
5,266
+992
+23% +$27.2K 0.02% 797
2024
Q1 		$108K Sell
4,274
-4,273
-50% -$101K 0.02% 802
2023
Q4 		$278K Buy
+8,547
New +$235K 0.06% 547

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AlphaQuest's CORT Position: Q1 2026 in Review

AlphaQuest sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 88 shares — an estimated $3.06K sold.

AlphaQuest first reported a position in CORT in Q4 2023 and held it in 9 quarters. The position peaked at $428K in Q3 2024. 352 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • AlphaQuest reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 88 Corcept Therapeutics shares in Q1 2026, an estimated $3.06K.
  • AlphaQuest first reported a position in Corcept Therapeutics in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Corcept Therapeutics position peaked at $428K in Q3 2024.
  • 352 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.